共 172 条
[1]
Waks AG(2019)Breast cancer treatment: a review JAMA 321 288-300
[2]
Winer EP(2017)De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen international expert consensus conference on the primary therapy of early breast cancer Ann Oncol 2017 28 1700-1712
[3]
Curigliano G(2013)Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial Lancet 381 805-816
[4]
Burstein HJ(2012)Clinical and biomarker predictors of side effects from tamoxifen Breast Cancer Res Treat 132 1107-1118
[5]
E PW(2005)Ovarian cysts in tamoxifen-treated women with breast cancer Eur J Obstet Gynecol Reprod Biol 120 104-106
[6]
Gnant M(2009)Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer N Engl J Med 361 766-776
[7]
Dubsky P(2005)Ovarian cyst formation in patients using tamoxifen for breast cancer Jpn J Clin Oncol 35 607-611
[8]
Loibl S(2004)Crossover trial for lipid abnormality in postmenopausal breast cancer patients during selective estrogen receptor modulators (SERMs) administrations Breast Cancer Res Treat 88 9-16
[9]
Davies C(2016)Clinical significance of fatty liver disease induced by tamoxifen and toremifene in breast cancer patients Breast 28 67-72
[10]
Pan H(2014)Toremifene for breast cancer: a review of 20 years of data Clin Breast Cancer 14 1-9